81 related articles for article (PubMed ID: 20486840)
1. Discrimination between postinfectious IgA-dominant glomerulonephritis and idiopathic IgA nephropathy.
Wen YK; Chen ML
Ren Fail; 2010 Jun; 32(5):572-7. PubMed ID: 20486840
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the significance of complement-related genes mutations in atypical postinfectious glomerulonephritis: a pilot study.
Xu F; Zhang C; Zhang M; Zhu X; Cheng S; Cheng Z; Zeng C; Jiang S
Int Urol Nephrol; 2024 Apr; 56(4):1475-1485. PubMed ID: 37845399
[TBL] [Abstract][Full Text] [Related]
3. IgA-dominant postinfectious glomerulonephritis: a case report.
Moreno-Alvarado R; Navarro-Blackaller G; De Leon-Pérez W; Armas-Eguizabal D; Chávez-Iñiguez J
Front Nephrol; 2023; 3():1284814. PubMed ID: 38022725
[TBL] [Abstract][Full Text] [Related]
4. Bacterial infection-related glomerulonephritis in patients with diabetes.
John EE; Roy S; Eapen JJ; Karuppusami R; Jose N; Mani SSR; Johny J; Alam R; Yusuf S; Thomas A; Valson AT; David VG; Varughese S; Alexander S
Nephrology (Carlton); 2023 Nov; 28(11):597-610. PubMed ID: 37492933
[TBL] [Abstract][Full Text] [Related]
5. [Progress in IgA-dominant infection-related glomerulonephritis].
Huang ZY; Chen CS
Zhonghua Nei Ke Za Zhi; 2023 Dec; 62(12):1507-1510. PubMed ID: 38044082
[TBL] [Abstract][Full Text] [Related]
6. AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
Paueksakon P; Najafian B; Alpers CE; Fogo AB
Am J Kidney Dis; 2024 Jan; 83(1):e1-e2. PubMed ID: 38129071
[No Abstract] [Full Text] [Related]
7. Role of the gut microbiota in the pathogenesis of IgA nephropathy.
Carney EF
Nat Rev Nephrol; 2024 Jun; 20(6):353. PubMed ID: 38684790
[No Abstract] [Full Text] [Related]
8. PROTECTing the kidneys in IgA nephropathy.
Reich HN; Barbour SJ
Lancet; 2023 Dec; 402(10417):2046-2047. PubMed ID: 37931627
[No Abstract] [Full Text] [Related]
9. Crescentic IgA Nephropathy Following Varicella Infection in a 7-y-old-Boy: Hitherto Unreported Association.
Sravani M; Deepthi B; Krishnasamy S; Vigneshwaran V; Ravi S; Gochhait D; Krishnamurthy S
Indian J Pediatr; 2023 Dec; 90(12):1263. PubMed ID: 37470960
[No Abstract] [Full Text] [Related]
10. Targeting APRIL to slow progression of IgA nephropathy.
Wang M
Nat Rev Nephrol; 2024 Jan; 20(1):6. PubMed ID: 38012265
[No Abstract] [Full Text] [Related]
11. Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review.
Kiryluk K; Freedberg DE; Radhakrishnan J; Segall L; Jacobson JS; Mathur M; Mohan S; Neugut AI
Kidney360; 2023 Aug; 4(8):1112-1122. PubMed ID: 37227924
[TBL] [Abstract][Full Text] [Related]
12. Variability in Diagnosis and Treatment of Recurrent IgA Nephropathy in Kidney Transplants: Results of Surveys of Renal Pathologists and Nephrologists.
Haas M;
Kidney Int Rep; 2023 Nov; 8(11):2486-2487. PubMed ID: 38025221
[No Abstract] [Full Text] [Related]
13. [Not Available].
Ammann S
Rev Med Suisse; 2023 Dec; 19(855):2419. PubMed ID: 38117116
[No Abstract] [Full Text] [Related]
14. Postinfectious Disorders of Gut-Brain Interaction: A Brainstorming Story.
Lambiase C; Bellini M; Chiarioni G
Clin Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38750868
[No Abstract] [Full Text] [Related]
15. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease.
Nasr SH; D'Agati VD
Nephron Clin Pract; 2011; 119(1):c18-25; discussion c26. PubMed ID: 21659781
[TBL] [Abstract][Full Text] [Related]
16. IgA dominant postinfectious glomerulonephritis: Report of two cases.
Rajakumar V; Mohamed SA; Kurien AA; Fernando ME
Indian J Nephrol; 2014 May; 24(3):181-4. PubMed ID: 25120298
[TBL] [Abstract][Full Text] [Related]
17. IgA-dominant postinfectious glomerulonephritis: not peculiar to staphylococcal infection and diabetic patients.
Wen YK; Chen ML
Ren Fail; 2011; 33(5):480-5. PubMed ID: 21545311
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Features of IgA-Dominant Postinfectious Glomerulonephritis.
Koo TY; Kim GH; Park MH
Korean J Pathol; 2012 Apr; 46(2):105-14. PubMed ID: 23109989
[TBL] [Abstract][Full Text] [Related]
19. STEC-HUS, atypical HUS and TTP are all diseases of complement activation.
Noris M; Mescia F; Remuzzi G
Nat Rev Nephrol; 2012 Nov; 8(11):622-33. PubMed ID: 22986360
[TBL] [Abstract][Full Text] [Related]
20. Infection-related glomerulonephritis: changing demographics and outcomes.
Nast CC
Adv Chronic Kidney Dis; 2012 Mar; 19(2):68-75. PubMed ID: 22449343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
